What's in Angion Biomedica Corp's pipeline?

Angion Biomedica Corp has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Angion Biomedica Corp's portfolio?

Top competitors by shared drug class: Akeso, AstraZeneca, Beijing InnoCare Pharma Tech Co., Ltd., Betta Pharmaceuticals Co., Ltd., Centre Leon Berard.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/angion-biomedica-corp.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Angion Biomedica Corp — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Angion Biomedica Corp pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ANG-3777	ANG-3777	phase 3	HGF mimetic	MET receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Akeso · 1 shared drug class
AstraZeneca · 1 shared drug class
Beijing InnoCare Pharma Tech Co., Ltd. · 1 shared drug class
Betta Pharmaceuticals Co., Ltd. · 1 shared drug class
Centre Leon Berard · 1 shared drug class
Chang-Ming Huang, Prof. · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
AB Science · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Angion Biomedica Corp:

Cite this brief

Drug Landscape (2026). Angion Biomedica Corp — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/angion-biomedica-corp. Accessed 2026-05-17.